Exchange: NASDAQ·Updated 09:29 PM EST

SLS News

News
all
press releases
‘Pharma Bro’ Shkreli Calls SLS Results ‘Sketch,’ Compares Leukemia Vaccine Data To Capricor’s Deramiocel
Martin Shkreli dismissed SLS’s trial data as statistically fragile, drawing a parallel between the company’s data and Capricor Therapeutics’ Deramiocel data.
Stocktwits
‘Pharma Bro’ Shkreli Calls SLS Results ‘Sketch,’ Compares Leukemia Vaccine Data To Capricor’s Deramiocel
Martin Shkreli dismissed SLS’s trial data as statistically fragile, drawing a parallel between the company’s data and Capricor Therapeutics’ Deramiocel data.
Stocktwits
More News
SELLAS Life Sciences Group, IREN, American Airlines Group, Applied Optoelectronics, BILL, Insight Enterprises, and AXT are the seven Mid Cap stocks to watch today, according to MarketBeat's stock screener tool. Mid-cap stocks are shares of companies with a medium-sized market value, generally betwe...
MarketBeat
Sellas Life Sciences: REGAL Hits, But The Data Leaves Too Many Questions Unanswered...
SeekingAlpha
Company plans to meet with the FDA and is preparing a biologics license application for the first half of 2027...
Quartz
SELLAS Life Sciences Group, Eli Lilly and Company, UnitedHealth Group, Moderna, Johnson & Johnson, CVS Health, and Stryker are the seven Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies involved in the healthc...
MarketBeat
SELLAS Life Sciences Group, Eli Lilly and Company, and Johnson & Johnson are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of companies that research, develop, manufacture, or sell medicines and related treatments. Fo...
MarketBeat
SELLAS Life Sciences Group, Moderna, Gilead Sciences, AbbVie, and Natera are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that use biotechnology to develop medicines, therapies, diagnostics, or other life-science produ...
MarketBeat
Greenwich said two research abstracts related to its experimental breast cancer drug were accepted for the San Antonio Breast Cancer Symposium, scheduled for December 8 to 11.
Stocktwits
Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) shares rose 169.8% to $20.16 during Tuesday's regular session. The market value of their outstanding shares is at $1.5 billion. As per the press release, Q3 earningsread more...
Benzinga
SELLAS Life Sciences Group (NASDAQ:SLS) Sets New 52-Week High - Time to Buy...
MarketBeat

Advertisement|Remove ads.